Related Experiment Video
Updated: Apr 26, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Cognition in breast cancer survivors: hormones versus depression
Naomi Seliktar1, Carolee Polek, Ari Brooks
1Interdisciplinary Research Unit, Drexel University, Philadelphia, PA, USA.
Objective:
Breast cancer survivors receiving hormone treatment and/or endorsing histories of receiving chemotherapy report changes in their cognitive capacity, which is often not supported by formal testing. To address these conflicting reports, this study examined survivors' applied cognitive capacity and its association with hormone treatment, depression, and selected demographics.
Methods:
A descriptive, correlational, cross-sectional survey design was employed. There were 357 women who completed a survey comprised of 69 questions. The survey included both investigator-developed questions and instruments from the PROMIS(®) system.
Results:
There were significant main effects for hormone therapy, race, and depression. Depression explained the largest portion of variance of the perceived decreases in cognitive function among breast cancer survivors.
Conclusions:
Survivor complaints of changes in cognitive function may be a predictor for evaluating the presence of mood disorders and less a function of hormone therapy or chemotherapy history.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Depression: Overview
The Influence of Cognition on Affect
Cancer Survival Analysis
Disorders of the Female Reproductive System
Cognitive Therapy